chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Received flu shot 11/7/02 during shot clinic. Developed decreased range of motion. No swelling. Saw doctor 12/9/02 X-ray was done. Celebrex was prescribed. Saw doctor again on 12/11/02. Has completed Celebrex; still having soreness in right shoulder.
4-5 hours after flu vaccine pt contacted student health with complaints of eyes burning and hurting, shortness of breath, fever. Symptoms reduced over 24 hours. Also with headache and back ache. Didn't seek care in clinic.
~12 hours following vaccination, and now for about 12 hours, fatigue, sleeplessness, malaise, chills, shakes, elevated temp (100.4), elevated resting heart rate (73 v. normal of 50), light-headed, muscle aches, stomach pain, diarrhea,  runny nose, dry cough
Patient had hard bump at injection site, which was itchy, red and warm to the touch.  Her arm was red and puffy for a couple of days afterward and she had a headache.  All symptoms cleared up within 7 days.
This spontaneous report as received from a Nurse refers to unspecified patients of unknown age and gender. On a unknown date in 2014 (also reported as since 2014) the patient was vaccinated with PNEUMOVAX 23 (lot number and expiry date unknown) (dosing regimen and frequency unknown) for an unknown indication which was exposed to temperatures below the recommended range. No concomitant medications were reported. No adverse events were reported. The action taken with the therapy with PNEUMOVAX 23 was unknown. The outcome of the events was unknown. The relatedness of the events to the therapy with PNEUMOVAX 23 was unknown. No product quality issue was reported. This is one of two reports from the same source. Additional information has been requested.
On the 30th, I noticed my lymph nodes under my arms and breast was swollen and were painful. My arm hurt at the site. I have a fever of 103 for 24 hours. I went to the doctor. She just did a breast exam.
No adverse effects reported; Patient received MMR II on 8/30/2019 and then again on 9/3/2019.; This spontaneous report was received from a pharmacist referring to a male patient of unknown age.  Information about medical history and concurrent conditions was not provided.   On 30-AUG-2019, the patient was vaccinated with one dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (recombinant human albumin) (M-M-R II) (route subcutaneous; strength, dose, frequency, lot #, expiration date and were not reported) for prophylaxis with sterile diluent (STERILE DILUENT) (unknown lot number and expiration). On 03-SEP-2019 the patient was vaccinated with another dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live albumin status rHA (recombinant Human albumin) (M-M-R II) (lot # R036582, expiration date 17-DEC-2020) with sterile diluent (STERILE DILUENT) (lot #S003608, expiration date 22-NOV-2020) (inappropriate schedule of vaccine administration). No adverse effects reported.
I received the shot at the pharmacy at 3 PM and was told mild flu like symptoms might occur but since I had only a loss of appetite for a day with the first dose the pharmacist and I believed the same would be true this time.  I returned to work for the evening and had a 1/2 hour drive after that.  5-6 hours later I was OVERCOME with dizziness. I was not able to drive and once at home I continued with dry heaves, extreme dizziness, nausea for 4 hours. I was unable to move off a chair with out assistance.  The nausea subsided about 16-18 hours after the shot.  I did not feel 100% until at least 6 days later.  I had limited appetite and aches in my upper back.  The suddeness of this reaction was extremely scary and no warning from the provider other than " the usual" symptoms is very concerning because I could have been driving.  No indication that the 2nd dose could be worse than the first is also scary to individuals that had a mild time with #1 and falsely believed everything would be fine.  I have heard many of my friends have had this overwhelming nausea experience and others say they would rather have the shingles.   I hope the vaccine can be adjusted in some way to prevent this reaction and more education can be given to the person receiving it.
Pt said (R) arm swollen, hot from injection site to elbow, and pain. Low grade fever.
This spontaneous report as received from a registered nurse refers to an unspecified number of patients of unknown age and gender. On an unknown date, the patients were vaccinated with a dose of PROQUAD (route lot # and expiration date were not provided). On an unknown date, an unspecified number of patients received PROQUAD exposed to minus 14 degrees C for 6 hours. No adverse symptoms were reported. At the time of the report, the patients' status was unknown. This is one of several reports received from the same source. Additional information has been requested.
During night after receiving vaccine woke up due to pain in left arm.  Left upper arm red, very warm very painful about a level "7-8" Wobbly - felt difficult to walk, 100.4 fever just felt very out of it shaky and wobbly.  Noted red rash on chest and arms, face red and warm.  3:30 am 1/12/20
Urticaria of torso. Treated with Benadryl 50mg po Tid.
FATIGUE; ACHY BONES; ACHY MUSCLES; TROUBLE SLEEPING; LYING IN BED ALL THE DAY; This spontaneous report received from a patient concerned a 72 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included no alcohol use, non smoker, unspecified antibiotic allergy, and no drug abuse. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805022, expiry: UNKNOWN) dose was not reported, administered on 12-MAR-2021 to Left Arm for prophylactic vaccination. No concomitant medications were reported.  On 13-MAR-2021, the subject experienced fatigue. On 13-MAR-2021, the subject experienced achy bones. On 13-MAR-2021, the subject experienced achy muscles. On 13-MAR-2021, the subject experienced trouble sleeping. On 13-MAR-2021, the subject experienced lying in bed all the day. Laboratory data (dates unspecified) included: Ultrasound abdomen (NR: not provided) Fatty liver, gall bladder removed. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from fatigue, achy bones, achy muscles, and trouble sleeping, and the outcome of lying in bed all the day was not reported. This report was non-serious.
Had severe  migraine after second shot which had resolved. Recalled new onset nausea and pain.  Went to bathroom but did not throw up. Awoke on floor and hematoma on forehead as a result.  Nausea and pain resolved but now head ache (distinct from migraine)  from hematoma. No previous h/o syncope and none since.  Syncopal event was brief. Applied ice intermittently for 48 hours. Swelling relieved within several days, but bruising remained for approximately a week.
This spontaneous report was received from a registered nurse and refers to an unknown number of patients of unknown age and gender. No information about the patients' medical history, concurrent conditions, drug reactions or allergies and concomitant therapies was provided. On unknown dates, the patients were vaccinated with ZOSTAVAX, injection, subcutaneously (lot#, expiration date and dose were not reported) with diluent (lot# and expiration date were not reported) which was kept in frozen temperature conditions, less than - 15 degrees Celsius. No known side effects were reported. No previous temperature excursions were reported. Product quality complaint was not involved. This is one of the several reports received from the same reporter. Additional information has been requested.; Sender's Comments: US-009507513-11701USA013576: US-009507513-1701USA013577:
Varicella - Information has been received from a physician concerning a 2 year old female with no medical history who on 07 Apr 2000 was vaccinated with one dose of varicella virus vaccine live.  There was no concomitant medication.  Subsequently the patient experienced a mild case of chickenpox consisting of 3-4 pox, 2 acabs, one vesicle, and one papule.  Medical attention was sought.
Moderna Bivalent booster 0.25mcg was given to patient, wrong dosage was given to patient. Patient was to receive 0.5mcg.
pt inadvertently recv an intradermal inj of pnu imune 23 instead of  PPD;pt devel inj site rxn characterized by a 7cm by 5cm area of pain, redness & swelling;tx for pain w/a non-prescription med;pt recovered;pnu-imune 23 had been left  out;
tested positive for COVID yesterday; tested positive for COVID yesterday; This is a spontaneous report received from a contactable reporter (Consumer) from medical information team.  A 42-year-old male patient received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 03Oct2022, outcome "unknown" and all described as "tested positive for COVID yesterday". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (03Oct2022) Positive, notes: She (reporter) and her husband both tested positive for COVID yesterday. Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical course: she (reporter) and her husband (patient) both tested positive for COVID yesterday and were both prescribed Paxlovid at their request but haven't started taking it yet. They were triple vaccinated with the Pfizer COVID19 vaccines and have had COVID 4 or 5 times in between their vaccines.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202201204632 same reporter/vaccine/event, different patient;
Very high heart beat.  Lasted about 4-6 hours. Fever - lasted appoximately 48 hours Constant sweating , still persisting over 80 hours after vaccine administration, yet no fever at this time.
patient stated paralyisis day after of lower body for 30 minutes then went away and did not go for treatment
symtptoms started evening of vaccine dose. Felt fine in am.  found on floor by family brought to hosp by EMS, seizure disorder; didn't have the strength to get to bed due to fatigue, which is history. Also abd pain and diarrhea and myalgias. Mottled reticular rash diagnosis identified: Abdominal pain; Acidemia; Acute kidney injury; Lactic acidosis; Mottled skin; NSTEMI (non-ST elevated myocardial infarction); Right hip pain; Tachypnea; Weakness
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 71-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 03Mar2021 at 16:00 as dose 1, single (Lot number: EN6200), in left arm and on 31Mar2021 at 16:00 as dose 2, single (Lot number: ER2613) at the age of 69 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "hypothyroid" (unspecified if ongoing), notes: hypothyroid; "high cholesterol" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset Dec2022, outcome "unknown" and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of vaccination failure, covid-19. Paxlovid was given for COVID 19 treatment.
Headache, Myalgia & Arthralgia Narrative: Pain on injection site the same day, chills , fatigue, body aches and headache all night until the afternoon with Tylenol and unable to sleep to report to work 2/13/21.
Moderna vaccines on 7/17/21, 8/15/21 Tested positive for COVID by PCR on 12/11/21 Hospitalized 12/11-12/12/21 at medical center for COPD exacerbation
3 to 4 days post rcv vax pt devel infection @ the site of tetramune administration. Treated w/ antibiotic.  One of two pt from this site to devel inject site infection post vax;f/u indicates pat had erythema, induration at inject site;
Pt. notified me on 10-10-20 that the eveing of 10-09-20 she started running a fever and has body aches. These symptoms continued through Saturday. She reported to me again on Sunday that fever exceeded 102 degrees on Saturday evening. Sunday morning was better. I instructed her to follow up with PCP on Monday if not better but checked in on Monday and she was better.
C/O of rash on his entire body. Flush. BENADRYL 50 mg IM given.
I have red spots on my left arm and they have a little pus on them. I have tiny little pus spots on my arm from my forearm to my upper arm. They are extremely itchy. Then they came on my right upper arm. They were bulging or elevated from the surface of my skin a little bit. They have been infected and they are difficult to heal. I tried a combination of calamine and Caladryl, but that wasn't helping. I went to an after hours clinic to see a doctor. They prescribed me with Nix lice cream 1%. It has been helping to dry the spots up but they keep coming back. It's red around the pus site. I have been running a slight fever. I am somewhat lethargic. They are not healed completely healed, but they are looking better now.
This spontaneous report was received from a pharmacist and refers to a 63-year-old female patient. No information regarding the patient's medical history, concurrent conditions and concomitant medications was provided. On 24-AUG-2017, the patient was vaccinated with PNEUMOVAX 23 lot # N010105, expiration date: 15-NOV-2018, subcutaneously, to prevent from pneumonia. Concomitant therapies included influenza virus vaccine (unspecified). On 24-AUG-2017 (reported as "later that evening"), the patient experienced pain, redness and the injection site was hot to touch. The patient spoke to a medical personnel and she was treated with BENADRYL (reported as "Benedryl") and ice packs to the injection site. On an unknown date in 2017, the patient recovered from all of the events. The causal relationship between the events and PNEUMOVAX 23 was not provided.
Pt complained of general malaise, hives were noted on upper extremity after 20 min in observation. Pt also have consistent systolic elevated BP readings >200
Tingling in legs and arms; This is a spontaneous case initially received from other non-health professional (reference number SEQ18-0873) on 11-Feb-2018, concerning a female patient of unspecified age.  The patient's current condition included diabetes. The patient's concomitant medications were not reported.   On an unknown date, reported as 20 or 30 years ago, the patient was administered unspecified Flu Vaccine Seasonal (influenza vaccine, influenza virus vaccine polyvalent, dose, route of administration, anatomical location, batch number, expiry date: not reported) for an unknown indication.  On an unspecified date, an unknown amount of time after vaccination, the patient experienced tingling in legs and arms.  The outcome of the event was not reported.   This case was linked to report 201800451 (same reporter).  Follow up retrieved from VAERS (VAERS ID: 742250-1) reported to VAERS by non-health professional on 02-Jul-2018: VAERS ID was updated. Upon internal review, it was relaised that listedness of the event tingling was incorrect, hence it was corrected (unlisted to listed in flu vaccine cell subunit NVD and flu vaccine Egg split. Amended narrative accordingly.  Follow-up reported by other non-health professional [reference number: SEQ19-05971] on 31-Oct-2019: Patient's medical history added. Company causality updated to related. Additional reference number added. Narrative was amended accordingly.  Company Comment: The event of paraesthesia of limbs is considered related to Flu vaccine.; Sender's Comments: The event of paraesthesia of limbs is considered related to Flu vaccine.
Severe fatigue, headache, dizzy sensation, chills. Problem lasted about 2 weeks. Patient required extra rest in bed.
Patient's nephrotic syndrome relapsed, while on oral steroids, within 2 days of receiving the immunization.  She had a relapse in early March 2021 after being in remission since April 2019, and quickly achieved remission again on prednisone 40 mg daily which started 3/13/21.  She then relapsed with a urine protein/creatinine ratio of 1.5 seven days after completing the taper.  She started prednisone 40 mg daily again and achieved remission and began a prednisone taper.  Her age group became eligible for COVID vaccine, and she received #1 of the Pfizer vaccine on 5/14/2021 (on 30 mg prednisone/every other day, after 4 doses of prednisone 40 mg every other day),  She continued her taper but developed 3+ urine protein and swelling 2 days after COVID vaccine #2 on 6/8/21, and returned to daily prednisone 40 mg.  By June 25, 2021, she was urine protein negative for 5 days, and started alternate day therapy and a steroid taper.
This spontaneous report as received from a pharmacist refers to a 53 year old female patient. On 08-JUL-2014 the patient was vaccinated with ZOSTAVAX lot # K000327, expiration date: 05-MAR-2015, 0.65 ml, subcutaneous for vaccination. 24 hours after receiving ZOSTAVAX, the patient experienced redness at the injection site which was 3.5 inches in diameter. The patient also said she had difficulty breathing, she could "hardly feel a pulse" and it felt like her nasal passages were closed. The patient treated herself with Benadryl and recovered at unspecified time. The patient sought medical attention by calling the pharmacy. This is one of several reports received from the same reporter and same source. Additional information has been requested.
Initial coughing/respiratory; swelling of tongue and mouth; eyes congested; throat swelling, BP 180/100. ER treatment: Benadryl drip, two shots epinephrine over 4 hours, other drip; prednisone tablets 5 days following.
COVID; COVID; This is a spontaneous report from a contactable consumer reporting same events under the same suspect product for 3 patients. This is the second of 3 reports. A patient of unspecified age and gender received unknown dose number of BNT162B2 (PFIZER BIONTECH COVID-19 VACCINE, solution for injection) via an unspecified route of administration on an unspecified date as dose number unknown, single for COVID-19 immunisation. Medical history and concomitant medications were not reported. It was reported that 3 people died from COVID after getting Pfizer's Vaccine. Three (3) individuals had the Pfizer's shot and died from COVID. The patient died on an unspecified date. It was not reported if an autopsy was performed.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101441253 same reporter/drug/event, different patient;US-PFIZER INC-202101441268 Same reporter/vaccine/event, different patient; Reported Cause(s) of Death: COVID; COVID
I got what I have read is "Moderna arm".  A few days after that I became dizzy and could not really stand up.  It lasted for about 5 hours.
5/18/21 9:20pm - c/o general aches & soreness right arm 5/19/21 6:10pm - c/o general aches, sleepiness, soreness to right arm temp 99.8 5/20/21 11:21pm - redness adminstration site, redness & puffiness to eyes & face, arm very sore 5/21/21 11:02am - c/o pain at injection site, red, warm, swollen, afebrile 5/21/21 10:03p - arm red, warm, swollen at injection site, afebrile, states feels better today 5/25/21 4:27am - lethargic, tremoring, nausea, diarrhea, temp 103.4 pulse 128, SPO2 82%, sent to hospital
One day post vax, pt developed hives with welts mainly on trunk as well as became sick to the stomach with diarrhea.
Patient complained of jaw pain, dizziness and nausea with emesis X's 1 of bile looking substance. Patient also complained of sweating, heart pounding, achy, and headache. Patient was sick in bed x's 3 days. Patient states, "It feels like I had the flu - like symptoms. Patient denies diarrhea.
This spontaneous report was received from a nurse referring to a 19 year old patient of unknown age and gender. The patient's medical history, concurrent conditions, concomitant medications, and historical drugs were not reported. On an unknown date, the patient was vaccinated with VAQTA pediatric intramuscular (dose, frequency and anatomical location, were unknown) with lot # N005796 and expiration date 26-MAY-2018 for prophylaxis. No adverse effects reported.
pt recv vax & 4 days p/vax pt cholesterol increased from 186 to 300;pt has not as yet been retested;
virus symptoms returned; Difficulty Breathing; A temperature above 99 F; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 69 year-old male patient received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 29Mar2021 17:15 (Lot number: ER8733) at the age of 69 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Covid-19", start date: 06Jan2021, stop date: 26Jan2021, notes: Thought I had a flu; "CLL", start date: 2018 (ongoing), notes: Not taking medications., Green tea only; "Severe Headache" (unspecified if ongoing). Concomitant medication(s) included: TYLENOL taken for headache, start date: 11Aug2021, stop date: 11Nov2021. Vaccination history included: Bnt162b2 (Dose: 1st, Date: 08Mar2021, Time: 14:00, Anatomical Site of injection: left arm, Route of administration: Intramuscular, Batch/Lot number: EN6198, Expiration Date: 30Jun2021), administration date: 08Mar2021, when the patient was 69 years old, for Covid-19 immunization, reaction(s): "virus symptoms returned", "Mind fog", "Headache", "Body ache", "night sweating", "inability to concentrate", "sense of balance", "loss of appetite", "general feeling of exhaustion". The following information was reported: INFLUENZA LIKE ILLNESS (non-serious) with onset 30Mar2021 04:00, outcome "recovered" (03Apr2021), described as "virus symptoms returned"; DYSPNOEA (non-serious) with onset 30Mar2021 04:00, outcome "recovered" (03Apr2021), described as "Difficulty Breathing"; PYREXIA (non-serious) with onset 30Mar2021 04:00, outcome "recovered" (03Apr2021), described as "A temperature above 99 F". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of influenza like illness, dyspnoea, pyrexia.  Additional information: Prior Vaccinations (within 4 weeks) was reported as none. It was reported that after each vaccination, virus symptoms returned at no time did the patient have Difficulty breathing or a temperature above 99 F.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
consumer reports pt recvd vax 23NOV93 & local react occurred w/in hrs p/vax redness, swelling, pain extending to elbow; resolved p/4 days; systemic react onset 3 days p/vax-achy, flu-like sx, fever to 101; resolved p/3-4 days;
Information has been received from a physician concerning a 17 year old female with no pertinent medical history and no drug reactions/allergies who on 17-AUG-2007 was vaccinated with Gardasil.  There was no concomitant medication.  The day after administration of her first dose of Gardasil, on 18-AUG-2007, the patient developed widespread hives.  The patient had not experienced respiratory distress.  The patient presented to the physician's office for evaluation on 21-AUG-2007, but the details of the evaluation and the treatment plan were not provided by the physician.  As of 21-AUG-2007, the patient's widespread hives persisted.  Additional information has been requested.
Pt called Dr about 8 hours after injection with reported swollen, sore arm, swollen feet, swollen tongue, Dr advised she go to ER. Pt refused.